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Reduced nuclear binding of a DNA minor groove ligand (Hoechst 33342)
and its impact on cytotoxicity in drug resistant murine cell lines
S.A. Morgan, J.V. Watson, P.R. Twentyman & P.J. Smith
MRC Clinical Oncology and Radiotherapeutics Unit, MRC Centre, Hills Road, Cambridge CB2 2QH, UK.
Summary The reduced cellular uptake, and subsequent reduced nuclear availability, of cytotoxic agents is a
factor in the resistance of mammalian cells to anti-cancer drugs that act by interaction with DNA. The whole
cell uptake, nuclear binding and cytotoxicity of a DNA-specific ligand, Hoechst dye number 33342 (Ho342), has
been studied in cytotoxic drug resistant variants of a murine tumour cell line. Cell lines showing various
degrees of cross-resistance to adriamycin as a part of the phenotype of classical multi-drug resistance (MDR)
demonstrated a reduction in intranuclear Ho342 content, up to a maximum of 35% of the level found in the
parent as assessed by flow cytometry, despite similar levels of whole cell uptake determined using radiolabelled
ligand. Ability to limit nuclear accessibility of Ho342 correlated closely with cellular resistance to Ho342 and to
adriamycin. All drug resistant cell lines showed a significant increase in nuclear accessibility to Ho342 after
verapamil treatment, including a methotrexate resistant cell line. The methotrexate resistant variant, not
demonstrating MDR, showed reduced nuclear binding of Ho342 but increased cell kill associated with a
propensity to develop a population of cells showing extra DNA replication in response to Ho342 exposure.
Differences between cell lines in the relationship between Ho342-induced cell cycle perturbation and cell kill
supported the conclusion that modulation of several pathways of response to cytotoxic agents had occurred in
the development of drug resistance.
The clinical problem of acquired resistance to initially useful
cytotoxic agents remains of major significance, and the inves-
tigation of cellular resistance mechanisms in tumour cell lines
continues to generate hypotheses regarding this clinical situa-
tion. Prolonged exposure of mammalian cells in vitro to
certain chemotherapeutic agents can result in the develop-
ment of resistant sub-lines with cross-resistance to a number
of functionally unrelated drugs. Such 'classical' multi-drug
resistance (MDR) typically affects responsiveness to the anti-
cancer drugs adriamycin (ADM), vincristine (VCR) and col-
chicine (COL). The MDR phenotype is thought to reflect
increased active cellular efflux of these agents by a membrane
located, energy-dependent transport mechanism involving P-
glycoprotein (Gerlach et al., 1986; Endicott & Ling, 1989).
Presumably the mechanism of classical MDR effectively pro-
tects important intracellular targets by limiting their acces-
sibility to these cytotoxic agents, an explanation satisfactory
for the mitotic spindle inhibitors VCR and COL, but the
situation is less clear for ADM, where significant cell mem-
brane effects (Tritton & Yee, 1982) have been identified, in
addition to DNA damaging activity (Zwelling et al., 1981).
Ideally an evaluation of intracellular target protection afford-
ed by MDR should involve the use of an agent known to
exert its cytotoxic effects predominantly through interaction
with a single target (e.g. DNA), and whose delivery to this
target can be monitored in individual cells.
We have investigated the relationship between cytotoxicity
and the cellular capacity for intracellular target protection in
cells showing MDR using a DNA specific ligand, Hoechst
dye number 33342 (referred to as Ho342; Figure 1). Ho342 is a
bisbenzimidazole dye with a specificity for non-intercalative
binding at AT base pairs in DNA and minimal interaction
with RNA (Latt & Stetten, 1976). The related dye Hoechst
33258 (see Figure 1) has been used extensively as a DNA
stain (Zimmer & Wahnert, 1986). The more lipophilic deriv-
ative Ho342 is used as a vital nuclear stain in flow cytometry
(Latt, 1979) but can induce DNA damage, mutations and cell
death (Durand & Olive, 1982). Human cells with putative
deficiencies in DNA repair showed enhanced sensitivity to
Ho342 (Smith, 1984) and a mammalian cell mutant with
enhanced capacity to remove Ho342 from cellular DNA is
highly resistant to the cytotoxic action of the dye (Smith et
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Figure 1 Chemical structures of selected bisbenzimidazole dyes
and anthracyclines.
al., 1988). Thus the interaction of Ho342 with DNA appears
to be an important factor in the cytotoxicity seen at higher
concentrations of this agent (Zimmer & Wahnert, '986).
Unlike DNA-binding chemotherapeutic agents such as the
anthracyclines (e.g. doxorubicin and daunomycin; Figure 1),
the interaction of Ho342 with its target (the nucleus) can be
assessed by exploiting the considerable fluorescence enhance-
ment that occurs when bisbenzimidazole dyes bind non-
covalently to the minor groove of the DNA double helix
(Latt & Stetten, 1976); using flow cytometry (FCM), the
resulting Ho342-DNA fluorescence monitors specifically
nuclear dye uptake (Smith et al., 1985; Morgan et al., 1989).
The FCM technique also allows the effects of resistance-
modifying agents (verapamil, calmodulin inhibitors and Ca2 +
channel blockers; Tsuruo et al., 1982) to be quantified and
the kinetics of their actions defined (Krishan, 1987; Morgan
et al., 1989; Nooter et al., 1989).
The present study examines the relationship between target
protection and resistance in a series of murine cell lines
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initially selected for resistance to single anti-tumour agents
(namely: ADM, COL, methotrexate (MTX), VCR, or a
novel anthracycline, Roche product number 31-1215 (1215;
Twentyman et al., 1986b). The nuclear binding and cross-
resistance patterns of the cell lines used, investigated by
clonogenic assay, demonstrated participation of Ho342 in the
classical MDR pathway. The cytotoxicity study also incor-
porated a detailed analysis of Ho342 cell cycle perturbation in
an attempt to identify different cellular pathways for the
expression of drug-induced cell killing in drug resistant cells.
Materials and methods
Cell culture
The derivation of cytotoxic drug resistant variants from the
parent mouse mammary tumour cell line, EMT6/Ca/VJAC,
has been described previously (Twentyman et al., 1986a).
Briefly cells from the parent cell line were continuously
exposed to the cytotoxic agent to which resistance was being
induced; over approximately 6 weeks the cytotoxic drug con-
centration, chosen such that continued cell growth occurred,
could be progressively increased until ultimately the resulting
cell line was able to grow in a drug concentration highly
inhibitory to the parent cell line. Variant cell lines showing
different degress of resistance to the inducing agent have been
produced by a continuation of the same process; for this
study variant cell lines were used which had closely similar
cell cycle characteristics (Table I).
Cell lines were maintained in Eagles MEM with 20%
new-born calf serum, supplemented with 2 mM glutamine,
100 IU ml-' penicillin and 100 mg ml-' streptomycin (all
Gibco Biocult Ltd, Uxbridge, UK), at 37°C in 8% CO2 in
air. EMT6 lines grew as attached monolayers, and were
detached for experiments using a short exposure to trypsin/
EDTA in phosphate buffered saline (PBS).
Drug treatments
The exact concentrations of filter sterilised stock solutions of
Ho342 (CP Laboratories, Bishop's Stortford, UK; Figure 1)
were determined spectrophotometrically (molar extinction co-
efficient 4.1 104M-1 cm-' at 340 nm, pH 7.0). Adriamycin
(Farmitalia Carlo Erba, St Albans, UK; Figure 1) was stored
at -20°C at 500 mg ml- ' in distilled water. Where indicated
cells were exposed to VPL (Abbott Laboratories, Queen-
borough, UK) at 3.3 or 6.6tLM for 30 min at 37°C before
addition of Ho342. Cells were exposed to cytotoxic agents for
24 h under normal culture conditions (37°C, 92% air/8%
C02, culture medium as above).
Ho342 accumulation
Nuclear fluorescence assessment Attached cells in logarith-
mic phase of growth (1-3 x 106 per 9 cm dish), were exposed
to fluorochrome under standard culture conditions at 37°C
for 60 min before washing with buffer (10 mM Tris HCI,
100 mM NaCl, 10 mM EDTA, I mg ml-' bovine serum albu-
min, pH 8.0) at 4°C and rapid freezing on a dry ice/ethanol
bath; immediately before FCM analysis cells were thawed at
37°C, resuspended in buffer at 2 x 105 cellsml-', and
analysed using the MRC flow cytometer as described pre-
viously (Morgan et al., 1989), importantly sub-cellular debris
and cell clumps were excluded from analysis by electronic
gating on the basis of light-scatter signals and pulse-shape
analysis (Watson et al., 1985). Fluorescence excitation was by
a krypton laser tuned to 337 nm (200 mW light power)
recording three parameters: 90° light scatter (<370 nm) act-
ing as the master trigger, forward light scatter and fluores-
cence at 500 nm ± 5 nm wavelength, the median fluorescence
value for whole cell populations was determined.
Radiolabelled Ho342 accumulation Cells were treated in 96-
well plates, under normal cell culture conditions, with 3H-
Ho342 (obtained through the tritium labelling service of NEN
Research Products; supplied at a specific activity of 385
mCi mmol-1), the nominal concentration of which ranged
from 1O mM to 1O gM. After 60 min cells were washed twice
with PBS at 4°C, allowed to dry in air, and lysed in 0.5 ml of
0.1 M NaOH for 60 min; aliquots were neutralised and count-
ed in scintillation fluid (Aquasol). Assays were performed in
triplicate; two plates set up in parallel were trypsin/EDTA
detached for counting of total cell numbers and results ex-
pressed as radioactivity per 105 cells. Radiochemical purity of
Ho342 was determined by thin layer chromatography of tri-
ethylamine-treated samples using 20% methanol in dichloro-
methane. The dry chromatogram was developed by applying
5 fil volumes of calf thymus DNA (1 mgml-I PBS) along the
trace and examining under long wave UV-illumination.
Similar traces were observed for radiolabelled and unlabelled
Ho342 with greater than 40% of radioactivity associated with
a constituent that showed fluorescence enhancement with
DNA, the remaining activity not being associated specifically
with any other short UV-radiation-absorbing constituents.
Cytotoxic drug sensitivity testing
Cell cycle perturbation Attached cells in logarithmic phase
of growth were treated with cytotoxic agents in 6-well plates.
Cultures were washed with PBS at 4°C immediately before
trypsin/EDTA detachment, and cells were resuspended in full
culture medium at a density of 2 x 105 ml-' before staining,
using a rapid one-step DNA-staining technique for RNase
digested cells using ethidium bromide (50iLg ethidium
bromide ml-', 0.125% Triton X-100, ribonuclease 0.5 g
ml-'; 1:8 dilution with cell suspension; 10min at room tem-
perature: Taylor & Milthorpe, 1980). Details of the analysis
of cell suspensions by FCM, and the computer algorithm
used to determine cell cycle distribution have been published
previously (Watson et al., 1987). Where cytotoxic treatment
resulted in very pronounced disturbance of the normal cell
cycle distribution, and virtual complete loss of the G, pop-
ulation, this algorithm could not be used satisfactorily; in such
cases the frequency distributions were assessed by manual
setting of gates according to the G,- and G2-DNA positions of
the control sample (concordance of these two methods was in
all cases checked at the lower cytotoxic drug concentrations).
Table I Characteristics ofmurine cell lines
% cells in cell cycle Mean cellular
Selecting Drug conc. pha DNA content' Plating
Cell line drugy (fgml-') GI S G2/M (pgcell-') P-glycoproteind efficiencye
EMT6/P - - 47.5 39.6 12.9 15.0 + 62±4%
ARLO ADM 1.0 34.5 47.2 18.2 15.3 + + + + 69±3%
CR2.0 COL 2.0 36.7 44.8 18.5 15.3 + + + + + 38±8%
MR1.0 MTX 1.0 42.3 38.5 19.2 15.8 + 50±7%
VR1.0 VCR 1.0 43.6 35.4 21.0 16.4 + + + 69±4%
1215R Ro 31-1215 0.1 38.5 44.3 17.3 15.4 + + 54±4%
'Continuous exposure ofstock cultures. 'Typical values for exponential phase culture.cMean value for
whole population, exponential phase cells, with reference to human blood leucocytes, see text. dData from
Reeve et al. (1989), Twentyman et al. (1990) and Twentyman and Reeve (unpublished data). "Anthmetic
means (±s.e.) for 9-11 determinations.REDUCED NUCLEAR BINDING OF HOECHST 33342 961
Clonogenic assay Cells grown in the absence of cytotoxic
agents for 48 h were trypsin/EDTA detached, plated in fresh
medium at a density of 2 x 102 cells (for lower cytotoxic drug
concentrations) or 2 x 103 cells (for higher concentrations)
per 6 cm dish, and allowed to attach for 6-12 h before
cytotoxic drug exposure. Following drug treatments cultures
were washed twice with PBS and maintained in drug-free,
complete culture medium for 10 days without further
medium change, and assayed by counting of fixed, stained,
colonies.
Results
Cytotoxicity
The cross-resistance patterns of the various cell lines were
studied for ADM and Ho342. Clonogenic assay of cell sur-
vival following a 24 h Ho342 treatment (Figure 2 and Table
II), demonstrated a dose-dependent cell kill with all cell lines.
This was also observed with EMT6/P after acute, 1 h expo-
sures to Ho342 (data not shown) but the HoW2 concentrations
required were considerably higher (e.g. for EMT6/P a D80 of
> 10 JAM for a 1 h, compared to 0.03 JAM for a 24 h expo-
sure). This led to problems of Ho342 precipitation in the
phosphate based buffers at the concentrations required for
MDR cell lines. Thus, a 24 h exposure period to either ADM
or Ho342 was selected for assessment of clonogenicity.
Clonogenic assay of cell survival for the lines ARl.0 and
CR2.0 following ADM treatment (Figure 3 and Table II)
demonstrated similar and considerable degrees of resistance
to ADM, with resistance factors at the 10% survival level
(RFIo; see Figure 3 for definition) of 78 and 88 respectively.
The cell lines VRl.0 and 1215R showed an intermediate
degree of resistance, with RF10 values of 36 and 18 respec-
tively; the ADM resistance of MRl.0 was minimal, with an
RF1o of 1.2. The cytotoxic drug resistant cell lines also
showed a range of sensitivities to Ho342, the ranking of
resistance levels of the cell lines showing MDR being
AR1.0>CR2.0 > VR1.0> 1215R. This was essentially the
same as that found for resistance to ADM, for which the
ranking was ARL.0 and CR2.0 > VR1.0> 1215R, demon-
strating participation of Ho342 in the MDR phenotype. The
MRl.0 line, which does not have the features of classical
MDR (Table I), and showed no significant abnormality in
ADM sensitivity, showed increased sensitivity to the cyto-
toxic actions of Ho342 compared to EMT6/P (RFIO 0.24).
Ho342 uptake study
Ligand uptake in the six cell lines, as assessed by radio-
labelled Ho342 accumulation in the whole cell (Figure 4),
showed a direct correlation with fluorochrome concentration
(determined spectrophotometrically) over the range 10 nM to
10 1M (the maximum concentration limited by the ethanolic
stock solution) for all cell lines. No significant differences in
whole cell uptake were observed between the parent cell line
(EMT6/P) and the resistant variants studied. At the highest
Ho342 concentration studied (0I1JM) cellular dye loads were
calculated to be no greater than approximately 40 pmol per
10 cells. In contrast, nuclear fluorescence, indicating nuclear
binding of the ligand, although also dependent on concentra-
tion of the fluorochrome, demonstrated a non-linear relation-
ship, with clear differences between the maximal levels of
fluorescence for the variant cell lines (Figure 5, open triangles
indicating results in the absence of VPL). EMT6/P showed a
rapid increase in fluorescence up to 5 iJM Ho342, followed by a
much smaller increase in fluorescence between 5 and 10 JiM
Ho342, suggesting saturation of Ho342-DNA binding sites at
higher ligand concentrations. Least fluorescence was shown
by the ADM resistant and the COL resistant lines, ARL.0
and CR2.0, in which 10 JM Ho342 exposure produced 35%
and 42% respectively of the fluorescence produced in the
parent cell line, the shape of the fluorescence/drug concentra-
tion curves suggesting failure to saturate Ho342-DNA bind-
ing sites even at the highest fluorochrome concentration used.
In the remaining three drug resistant lines, MR1.0, VRL.0
and 1215R, there was a reduction of fluorescence compared
to that of the parent line, to between 80% and 90%. These
differences could not be accounted for on the basis of varia-
tions in cell cycle phase distribution or cellular DNA content
(Table I).
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Figure 2 Sensitivity of mouse tumour cell lines of Ho342: clono-
genic assay after 24 h exposure to drug; mean ± I s.e.m. of three
experiments each in quadruplicate; survival curves generated by
computer algorithm. Symbols: * EMT6/P; 0 AR1.0; A CR2.0;
A MR1.0; * VRL.O; 0 1215R.
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Figure 3 Sensitivity of mouse tumour cell lines to ADM: clono-
genic assay after 24 h exposure to drug; symbols as in Figure 2,
± 1 s.e.m. of quadruplicate plates; results of single typical experi-
ment; survival curves generated by computer algorithm; dashed
line indicates equivalent position of EMT6/P survival curve on
the smaller scale.
Table II Relative drug sensitivities ofmurine cell lines
Adriamycin Ho-33342
Cell line RF80 RF50 RFlo RF80 RF5s RFIo
AR1.O 40 54.0 78.3 19.7 37.1 -
CR2.0 107 89.2 88.1 16.7 13.2 7.76
MR1.0 1.6 1.24 1.17 0.042 0.12 0.24
VR1.0 30 31.7 35.8 9.7 6.1 2.4
1215R 5.0 9.5 18.2 1.03 1.21 1.3
Summary ofclonogenic assay results shown in Figures 2 and 3. The
resistance factor (RF) refers to: (dose yielding x% survival for
variant/dose yieldingx% survival for EMT6/P) measured at 80, 50 and
10% survivallevels. Cell linesarereferredtobytheselectingagentused,
e.g. EMT6/ARI.0 as AR1.0.962 S.A. MORGAN et al.
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Figure 4 Whole cell uptake of Ho342 as assessed by 3H-Ho342
exposure for 60 min. Symbols as in Figure 2.
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Figure 5 Nuclear binding of dye assessed by FCM after expo-
sure of whole cells to Ho342 at various concentrations for 60 min:
median fluorescence of whole population (104 cells analysed)
expressed as a percentage of that of EMT6/P cells after 60 min
treatment with Ho342 10 JM. Symbols: A control; 30 min to VPL
at either 5 gM (0), or 2.5 AM (-).
The acute effect of VPL exposure on the binding of Ho032
to DNA was evaluated in the parent and resistant cell lines.
EMT6/P cells exposed to VPL for 30 min before the addition
of Ho342 showed a small increase (10%) of Ho342-DNA
fluorescence, seen at 51&M Ho342 concentration only (Figure
5). Again, the lack of enhancement by VPL of the fluores-
cence produced by exposure of EMT6/P to 10I1M HO342
suggested saturation of DNA binding sites at this higher
concentration of fluorochrome. All resistant cell lines showed
VPL responsiveness at 3.3 jaM concentration, with little addi-
tional effect of increasing VPL concentration to 6.69AM. VPL
increased the nuclear binding of DNA to Ho342 (nuclear
fluorescence) in the resistant cell lines CR2.0 and MR1.0 to
that of the parent line, exposed to Ho342 in the absence of
VPL; indeed VPL pre-treatment was able to increase the
nuclear fluorescence ofVR1.0 and 1215R to levels above that
of the parent line (for example, VR1.0; 10 LM Ho342 gives
115% the fluorescence of EMT6/P). In contrast the Ho342-
DNA fluorescence of the ADM resistant line, EMT6/AR1.0,
increased with VPL, but not to that level shown by the
parent line even with the higher concentration of VPL. We
conclude that there are considerable differences between
drug/nuclear target interaction in drug resistant cells detect-
able by Ho342-DNA fluorescence, but not apparent if whole
cell uptake is considered.
The expected ranking of cellular resistance, predicted from
the cellular capacity to limit Ho342-DNA interaction is
AR1.0>CR2.0 >> VRL.0> 1215R>MR1.0>EMT6/P; a
comparison of this ranking with the survival data presented
above shows a close correlation between resistance and the
limitation of the Ho342-DNA binding. However a clear
exception to this correlation is the MRL.0 cell line, in which
reduced nuclear availability of the fluorochrome compared to
the parent cell line was demonstrated by FCM, but which
showed increased sensitivity to Ho342 assessed by clonogenic
assay.
Cell cycleperturbation producedby cytotoxic agents
Cell cycle perturbation of an asynchronously growing
population was examined at 24 h after cytotoxic drug expo-
sure. Preliminary studies (data not shown) indicated the sen-
sitivity of EMT6/P to ADM by an increase in the number of
cells in G2/M (G2 arrest) at ADM concentrations of less than
10 jaM, while these concentrations produced no significant
increase in G2/M proportion in the MDR cell lines, ARL.0,
CR2.0, VR1.0 and 1215R. MR1.0 showed only a small in-
crease in the G2/M proportion at the highest (10 tLM)
cytotoxic concentration (data not shown). Exposure to Ho342
(Figure 6) produced two effects on the cell cycle distribution.
Firstly there was an accumulation of cells in G2/M phase,
which occurred at lower Ho342 concentrations in the lines
EMT6/P and MR1.0 compared to AR1.0, CR2.0 and VR1.0
lines, indicating the greater sensitivity of EMT6/P and
MR1.0; this did not occur to any significant degree in the
1215R line. Secondly, a population ofcells with high levels of
DNA (i.e. HD cells) developed, which was seen with all cell
lines but occurred at the lowest cytotoxic concentrations, and
to the greatest extent, with MRI.0. HD cells developed in the
1215R line even though there was no significant increase in
the proportion of G2/M cells. G2 arrest, or HD cell
appearance, was associated with a G1 emptying in all cell
lines suggesting the absence of a G,/S phase block. However
under these conditions, with a 24h drug exposure, a net
depletion of S phase was only observed for MRL.0 cells, with
all other cell lines showing either no change, or a net gain in
S phase.
Relationship ofcell cycleperturbation to cell viability
If modification of nuclear binding of Ho342 by the variant
EMT6 cell lines is the only influence on cytotoxicity of this
agent, then a similar dose modification effect should be seen
for both clonogenicity and cell cycle perturbation in drug
resistant cell lines. However, there may also be underlying
differences in the manner in which cytotoxicity is effected in
drug resistant cells, which could lead to a divergence between
the cytotoxic drug dose modification required for one mode
of evaluation of cytotoxicity, compared to that for the other.-
We have considered the association between cytotoxicity, as
indicated by reduction of cell viability (clonogenicity), and
cell cycle perturbation (specifically, the arrest ofcells in G2/M
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Figure 6 Effect of 24 h exposure to Ho342 on cell cycle distribution in mouse tumour cell lines: expressed as percentage change in
the proportion of cells in each phase in untreated control samples; means ± I s.e.m. of three experiments; 0 GI, * S, and A G2/M;
additionally the appearance of a population (HD; 0) with increased DNA content is shown together with the total recruitment of
cells into G2/M and HD (U) populations.
and the generation of HD cells). Figure 7 shows how these
two parameters correlate for each cell line at given Ho342
concentrations. (Preliminary analyses indicated that G2 arrest
alone was a relatively insensitive indicator of cell kill in
EMT6 cell lines unless the concomitant arrest of cells in the
HD phase was also considered.) A simple correlation
between cell kill and cell cycle arrest might be expected to
result in all values distributed along a straight line, with
distance from the origin indicating either higher drug concen-
tration or greater cellular sensitivity; EMT6/P cells demon-
strated such a relationship (Figure 7, continuous line). The
ARl.0 cell line showed very similar distribution of results to
EMT6/P, with a close association of cell cycle changes with
cell kill up to 0.6 fractional cell kill. At high Ho342 concentra-
tions cell cycle changes for EMT6/P were less than that
expected for the degree of cell kill, suggesting that cell arrest
was occurring in all phases of the cell cycle at these concen-
trations ofdye, an effect observed with other cytotoxic agents
(Barlogie et al., 1976). The other cell lines examined showed
divergence from the results of EMT6/P and ARl.0; CR2.0
and VRl.0 showed less cell cycle change for the same range
of fractional cell kill, whereas 1215R showed an intermediate
response. Figure 7 also clearly shows the relative hypersen-
sitivity of MRl.0 to Ho342, with high proportions of cells
arrested in G2/M and the development of HD cells.
Discussion
We have demonstrated varying degrees of suppression of
nuclear binding of a DNA interactive fluorochrome, Ho342, in
the drug resistant variants of a murine tumour cell line. In
EMT6/P
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various Ho042 concentrations (shown in Figures:
bols as in Figure 2.
those cell lines that showed both cross-resis
and changes associated with classical MDR
ranking of DNA target protection (reduction
Ho342 content) was the same as both the ran
resistance to Ho342 (ARI.O>CR2.0>> V
and the ranking of resistance to ADM
CR2.0 >> VRl.0> 1215R). These findings
murine cell lines examined, previous observati
al., 1981; Morgan et al., 1989) that the celli
mechanism of classical MDR operates on H(
of nuclear target protection from Ho342 was
relate closely with the degree of cellular resist
interactive drug in the variant cell lines show
effect of VPL in reversing the nuclear exclusic
greatest on those cell lines showing greatest
hyper-expression (ARL.0, CR2.0). However,
1215R, VPL increased Ho342 uptake to levels
EMT6/P, suggesting that the differing capacit)
in MDR cell lines may mask underlying diffe
accessibility, which can be revealed by maxin
the efflux mechanism.
The use of radiolabelled Ho342 to moni
uptake did not indicate differences between
revealed by the fluorescence technique for int
content. Reasons for this difference may inc
cell surface binding of radiolabelled Ho342 or
effect of the background radioactivity not;
DNA binding ligand (see Materials and mett
ate studies (Coley et al., 1989a,b; Twentyman
has been noted that the AR1.0, CR2.0, and I
show significant reductions in the whole cell a
a radiolabelled anthracycline daunomycin anc
lines are also responsive to verapamil for the
of resistance to ADM. It is possible that the
and the bisbenzimidazole dyes differ in the
disposition and sequestration. In the case of
lines, a second, intra-cellular verapamil-sensiti'
ing the access of fluorochrome to the nuclei
for Ho342. Whether such a second level
associated with a P-glycoprotein-like efflux r
only be speculated upon although subcellula
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dependence of Ho342 upon DNA-interaction tc
icity (see Introduction), we suggest that the I
method is a more appropriate method for dete
to Ho342. Furthermore, the findings are per
MDR drugs that may require access to discrete nuclear
targets (e.g. topoisomerase poisons such epipodophyllotoxins
and aminoacridines; Glisson & Ross, 1987).
An unexpected finding was the reduced nuclear accessi-
bility of Ho342 in MR1.0 cells, since P-glycoprotein hyper-
expression (i.e. above the basal level found in EMT6/P) has
not been demonstrated in this cell line (TableI), and resis-
tance selection involved an agent, MTX, not typically
involved in classical MDR. Moreover the whole cell uptake
of tritiated daunomycin was not found to be reduced in this
cell line (P.R. Twentyman, unpublished data). Although
showing a smaller reduction in intranuclear content of Ho342
than any other of the resistant lines test, there was a clear
response of the MR1.0 line to the resistance modifier VPL,
which increased the fluorescence to that of the parent,
EMT6/P, line. There appears to be a range of expression of
the mdrl gene in normal and tumour tissues (Fojo et al.,
1987; Goldstein et al., 1989; Endicott & Ling, 1989), and it
has been suggested that gene amplification or hyper-express-
0.8 1.0 ion may reflect a non-specific 'stress response' of the cell. The
induction of a VPL sensitive mechanism controlling nuclear
into G2/M and accessibility to Ho342 in the MR1.0 cell line could be a
iye-treated cells non-specific response of these cells to the stress of drug
d in Figure 2) selection without functional significance in the mechanism of
rviving cells) at resistance to MTX, but this does not explain absence of
2 and 6). Sym- detectable P-glycoprotein hyper-expression. It is also possible
that VPL has activity on an alternative pathway in such drug
resistant cells. We note that although the median fluorescence
values quoted may have obscured the presence of a sub-
tance to ADM population of VPL-sensitive cells showing highly modified
(Table I), the Ho342 uptake, this was not apparent upon analysis of the
in intranuclear FCM data that showed a single population of cells, with a
iking of cellular narrow range of fluorescence values, for each of the cell lines
'Rl.0> 1215R), examined.
I (ARl.0 and The ranking of five of the cell lines (P> 1215R>VR1.0>
extend, to the CR2.0>ARI.0) on the basis of nuclear fluorescence inten-
ions (Lalande et sity was exactly that found for Ho342 sensitivity. However,
ular drug efflux nuclear uptake alone does not explain the enhanced sen-
1342. The degree sitivity of MR1.0 to Ho342 compared to EMT6/P despite a
shown to cor- reduced nuclear content of the ligand in the MR1.0 cell line.
ance to a DNA There remains the possibility that differences in cytotoxicity
ring MDR. The result from non-uniform distribution of the ligand within the
on of Ho342 was genome, with binding to more critical portions of the genome
P-glycoprotein in particular cell lines causing toxicity that is not indicated by
in VR1.0 and their total nuclear binding of Ho342.
above that of In an attempt to determine the nature of the cellular
yfor drug efflux responses to Ho342 in the various cell lines we have assessed
rences in DNA the relationship between cell cycle perturbation assay and
nal blocking of clonogenicity. Conventionally COL is used as an arresting
agent to determine cell cycle delay in the absence of cell
itor whole cell division. However, this stathmokinetic approach would have
i the cell lines been complicated by the known resistance of some of these
:ranuclear Ho342 lines to COL. Accordingly, here we have monitored the
lude significant relative changes in each cell cycle phase compared to the
some masking untreated cells. Although differences in cell cycle duration
associated with and the rate of G2 recruitment might interfere with this
iods). In separ- method of assessment, no such differences were in fact
et al., 1990) it observed when camptothecin (a topoisomerase type I inhib-
VR1.0 cell lines itor to which all of these cell lines show identical sensitivity
iccumulation of and similar rates of recruitment into G2 delay) was used as
I that these cell the arresting agent (S.A. Morgan et al., unpublished data).
partial reversal Surprisingly, only AR1.0 showed a control response suggest-
anthracyclines ing that Ho342 induces cell death by qualitatively different
,ir intracellular means in the other cell lines.
the MDR cell Cell cycle analysis demonstrated the development of a
ve barrier limit- hyperdiploid population of cells in all cell lines as a result of
as may operate exposure to Ho342. Again the qualitative difference in cellular
of control is responses to Ho342 is highlighted by the unusual propensity of
mechanism can the MRLO. cell line (given the reduced Ho342 uptake in these
tr fractionation cells) to develop hyperdiploid cells at low dye concentrations.
ity. Given the This propensity may reflect a facility for DNA replication
) effect cytotox- without cytokinesis that has been observed in MTX resistant
low cytometric variants of other cell lines (Schimke, 1986).
cting resistance The present study shows that cell lines which differ in
tinent to those Ho342 sensitivity do not always show the expected changes inREDUCED NUCLEAR BINDING OF HOECHST 33342 965
cell cycle perturbation (Figure 7). Thus some MDR cell lines
(e.g. CR2.0 and VRl.0) may express modifications in path-
ways which affect ligand sensitivity additional to the protec-
tion of cellular DNA by the rapid cellular efflux of ligand
molecules (e.g. ability to arrest cell cycle progression follow-
ing the accumulation of genomic damage). The use of a
DNA-specific ligand to analyse the relationship between
cytotoxicity and nuclear location has revealed a spectrum of
responses in drug resistant cells not predicted from their
known degrees of expression of the classical MDR pheno-
type. We conclude that MDR can involve the modification of
more than one cellular pathway controlling cytotoxic drug
responsiveness, and that the flow cytometric approach de-
scribed here may be useful in assessing such characteristics in
human tumour biopsies.
The authors gratefully acknowledge the support and encouragement
of Professor N.M. Bleehen.
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